期刊文献+

D-二聚体与缺血修饰白蛋白联合检测在心力衰竭中的应用价值 被引量:2

Application value of D-dimer and ischemia modified albumin for combined detection of heart failure
下载PDF
导出
摘要 目的探讨联合检测D-二聚体与缺血修饰白蛋白(IMA)诊断心力衰竭的临床价值。方法 42例心力衰竭患者作为心力衰竭组(心功能Ⅱ级19例、Ⅲ级16例、Ⅳ级7例),42例进行体检的健康人作为健康组,检测两组D-二聚体、IMA及B型脑钠肽(BNP)水平,并进行比较;同时常规治疗心力衰竭患者,并检测不同心功能患者治疗后D-二聚体、IMA、BNP水平。结果心力衰竭组D-二聚体、BNP、IMA水平分别为(1.31±0.24)μg/ml、(941.8±144.2)pg/ml、(91.5±12.5)U/ml,均高于健康组的(0.20±0.06)μg/ml、(127.6±41.8)pg/ml、(67.2±10.7)U/ml,差异均具有统计学意义(P<0.05)。治疗后心功能Ⅳ级患者D-二聚体、BNP、IMA水平均高于心功能Ⅱ级与心功能Ⅲ级患者,差异均具有统计学意义(P<0.05);治疗后心功能Ⅲ级患者D-二聚体、BNP、IMA水平均高于心功能Ⅱ级患者,差异均具有统计学意义(P<0.05)。结论联合检测D-二聚体与IMA可有效诊断心力衰竭,并对治疗后效果予以评估,心功能越差者治疗效果越差,值得推广。 Objective To discuss the clinical value of D-dimer and ischemia modified albumin(IMA) for combined detection of heart failure. Methods There were 42 heart failure patients as heart failure group(19 cardiac function grade Ⅱ cases, 16 grade Ⅲ cases and 7 grade Ⅳ cases), and 42 healthy people as healthy group. The D-dimer, IMA and B-type natriuretic peptide(BNP) level in two groups was detected and compared. The patients with heart failure were received routine treatment, and the levels of D-dimer, IMA, BNP after the treatment of patients with different grades of heart function were detected. Results Heart failure group had D-dimer, BNP and IMA level respectively as(1.31±0.24) μg/ml,(941.8±144.2) pg/ml and(91.5±12.5) U/ml, which were all higher than(0.20±0.06) μg/ml,(127.6±41.8) pg/ml and(67.2±10.7) U/ml in healthy group, and their difference was statistically significant(P〈0.05). After treatment, cardiac function grade Ⅳ patients had higher D-dimer, BNP and IMA level than grade Ⅱ and Ⅲ patients, and their difference was statistically significant(P〈0.05). After treatment, cardiac function grade Ⅲ patients had higher D-dimer, BNP and IMA level than grade Ⅱ patients, and the difference was statistically significant(P〈0.05). Conclusion Combined detection of D-dimer and IMA can effectively diagnose heart failure. The effect of treatment after treatment is evaluated. The worse the heart function is, the worse the treatment effect. It is worth popularizing.
作者 陈国军 CHEN Guo-jun(Department of Clinical Laboratory, Guangdong Taishan Traditional Chinese Medicine Hospital, Taishan 529200, Chin)
出处 《中国实用医药》 2018年第10期12-14,共3页 China Practical Medicine
关键词 D-二聚体 缺血修饰白蛋白 心力衰竭 B型脑钠肽 D-dimer Ischemia modified albumin Heart failure B-type natriuretic peptide
  • 相关文献

参考文献9

二级参考文献70

  • 1韩天,高明.监测血脑利钠肽(BNP)评价68例老年心功能不全疗效及预后[J].吉林医学,2004,25(10):58-58. 被引量:9
  • 2骆雷鸣,范利,李妍涵,顾杰,薛浩,曾强,刘静,杨雪,朱兵,吴红梅,刘国树,叶平.急性下呼吸道感染增加老年慢性心力衰竭患者血栓危险的临床观察[J].中华老年医学杂志,2007,26(6):413-416. 被引量:8
  • 3吴波,张书富,陈德,马瑾,周依蒙,华尔铨.脑钠肽与高血压左室重塑、左室功能的关系[J].临床心血管病杂志,2007,23(7):510-512. 被引量:10
  • 4Ritchie RH, Rosenkranz AC, Kaye DM. B-type natriuretic peptide: endogenous regulator of myocardial structure, biomarker and therapeutic target[J]. Curr Mol Med, 2009,9 (7):814-825.
  • 5Mongirdiene A,Kursvietiene L,Kasauskas A. The coagulation system changes in patients with chronic heart failure [J]. Medicina ( Kaunas), 2010,46 (9) : 642-647.
  • 6Carpenter CR, Keim SM, Worster A, et al. Brain natriuretic peptide in the evaluation of emergency department dyspnea: is there a role? [J]. J Emerg Meal,2012,42(2) :197-205.
  • 7Porapakkham P, Porapakkham P, Zimmet H, et al. B-type natriuretie peptide-guided heart failure therapy:a meta-analysis [J]. Arch Intern Med,2010,170(6):507-514.
  • 8Nishikimi T, Kuwahara K, Nakao K. Current biochemistry, molecular biology,and clinical relevance of natriuretic peptides [J]- J Cardiol,2011,57(2) :131-140.
  • 9Marcucei R, Gori AM, Giannotti F, et al. Markers of hypercoagulability and inflammation predict mortality in patients with heart failure[J]. J Thromb Haemost, 2006,4 (5) : 1017-1022.
  • 10Zorlu A,Yilmaz MB, Yueel H, et al. Increased d-dimer levels predict cardiovascular morta[Jity in patients with systolic heart failure[J]. J Thromb Thrombolysis, 2012,33 (4) : 322-328.

共引文献78

同被引文献19

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部